Health IT

Drug regulatory authority to adopt e-Governance

The Central Drugs Standard Control Organisation plans to link its systems to the national network operating system to put all data on public domain

The Central Drugs Standard Control Organisation plans to link its systems to the national network operating system to put all data on public domain

cdsco_logo

Mumbai: With a view to strengthen the drug regulatory system in the country, the Central Drugs Standard Control Organisation (CDSCO) has decided to adopt e-Governance, add skilled manpower to its workforce along with capacity building and take new measures to ensure smooth delivery of services to benefit the patients across the country.

This strategic decision was taken recently during the drug consultative committee (DCC) meeting in Delhi.

“We plan to increase the number of skilled manpower by at least 1,000 people at the centre in the coming years. At the same time the centre has also asked the state drug authorities to send their proposal for manpower and capacity building so as to initiate steps to further their cause, Drug Controller General of India Dr G N Singh said.

He informed that many states have already started the project of revising their existing system to upgrade and meet the current needs by bringing in and adopting regulatory changes that will be effective and helpful in the uniform implementation of the Drugs and Cosmetics Act (D&C Act) and Rules throughout the country.

Our aim is to make the Indian drug regulatory system into an efficient and effective regulatory body so as to adopt best patient centric services. We are at present working on exploring the possibility of linking our existing systems to the national network operating system so that all the data acquired by us relating to patient safety and drug information and its use, can be put on public domain for the patients from all over the country to access, Dr Singh added.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on


Most Popular

SUBSCRIBE OUR NEWSLETTER
200000+ Subscribers read it every day.
Subscribe Newsletter
To Top